Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes
- PMID: 1415203
- DOI: 10.1016/s0272-6386(12)70298-6
Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes
Abstract
Vancomycin clearance was measured in five patients during dialysis with cuprophane (CU), polysulfone (PS), cellulose triacetate (CT), and polyacrylonitrile (PAN) dialyzers. Vancomycin was significantly cleared during routine high-flux (HF) hemodialysis (HD) with the latter three membranes, but not by CU. Postdialytic rebound of serum vancomycin concentrations was noted following HF dialysis, necessitating use of a two-compartment pharmacokinetic model. Measurement of serum vancomycin concentration immediately postdialysis significantly overestimates intradialytic removal, possibly resulting in inappropriate dose adjustment. Vancomycin infusion during HF HD results in significant drug removal during its administration to the patient, complicating the calculation of an adequate dose.
Similar articles
-
Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics.J Am Soc Nephrol. 1995 Oct;6(4):1284-90. doi: 10.1681/ASN.V641284. J Am Soc Nephrol. 1995. PMID: 8589298 Clinical Trial.
-
Comparison of the effects of three haemodialysis membranes on vancomycin disposition.Int Urol Nephrol. 1994;26(2):223-8. doi: 10.1007/BF02768291. Int Urol Nephrol. 1994. PMID: 8034435
-
Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease.Am J Kidney Dis. 1995 Sep;26(3):469-74. doi: 10.1016/0272-6386(95)90493-x. Am J Kidney Dis. 1995. PMID: 7645555
-
Vancomycin clearance with high-flux dialysis membranes.Int J Artif Organs. 1998 Mar;21(3):131-3. Int J Artif Organs. 1998. PMID: 9622110 Review. No abstract available.
-
Vitamin B6 and hemodialysis: the impact of high-flux/high-efficiency dialysis and review of the literature.Am J Kidney Dis. 1996 May;27(5):680-6. doi: 10.1016/s0272-6386(96)90103-1. Am J Kidney Dis. 1996. PMID: 8629628 Review.
Cited by
-
Construction of a prediction model for drug removal rate in hemodialysis based on chemical structures.Mol Divers. 2022 Oct;26(5):2647-2657. doi: 10.1007/s11030-021-10348-7. Epub 2022 Jan 1. Mol Divers. 2022. PMID: 34973116 Free PMC article.
-
Pharmacokinetic optimisation of vancomycin therapy.Clin Pharmacokinet. 1995 Apr;28(4):327-42. doi: 10.2165/00003088-199528040-00005. Clin Pharmacokinet. 1995. PMID: 7648760 Review.
-
Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation.BMC Nephrol. 2023 Sep 14;24(1):270. doi: 10.1186/s12882-023-03314-y. BMC Nephrol. 2023. PMID: 37710245 Free PMC article.
-
Biopsy-proven vancomycin-induced acute kidney injury: a case report and literature review.BMC Nephrol. 2018 Mar 27;19(1):72. doi: 10.1186/s12882-018-0845-1. BMC Nephrol. 2018. PMID: 29587650 Free PMC article. Review.
-
Drug dosing during intermittent hemodialysis and continuous renal replacement therapy : special considerations in pediatric patients.Paediatr Drugs. 2004;6(1):45-65. doi: 10.2165/00148581-200406010-00004. Paediatr Drugs. 2004. PMID: 14969569 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous